Metabolic syndrome in rheumatoid arthritis: role of adiponectin (preliminary results)
The clinical value of the disorders and diseases integrated within the metabolic syndrome (MS) is in the combination of traditional risk factors for cardiovascular diseases (CVD), which significantly accelerates the development of cardiovascular events (CVEs). The detection rate for MS in patients w...
Saved in:
Main Authors: | Yulia Nikolaevna Gorbunova, T V Popkova, L V Kondratyeva, D S Novikova, E N Aleksandrova, M V Cherkasova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2013-11-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1151 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipocytokines in early rheumatoid arthritis: relationship to pro- and anti-inflammatory markers
by: L. V. Kondratyeva, et al.
Published: (2019-01-01) -
Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01) -
Risk factors for venous thromboses in patients with rheumatoid arthritis
by: M. A. Satybaldyeva, et al.
Published: (2019-01-01) -
CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01) -
The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)